We certainly have a problem with patenting life essential medicines or any other public good, but in a sense, that's a separate philosophical issue. We think there's a social mortgage on all intellectual property, and so does international law. The patent question aside, because we don't really get into patents, we believe that regardless of what the patents say, governments should not have to pay the price that the brand names are asking. Most countries negotiate much lower prices through bulk purchasing agreements, which the Europeans do—
On January 28th, 2014. See this statement in context.